Cytrellis - FloodGate Medical

Shaping the Future of Aesthetic Possibilities

About Us

From our inception, our vision was to create truly novel advancements in the aesthetics industry. Based on the pioneering work of leading dermatologists and plastic surgeons, we created an entirely new technology known as the ellacor® system, which is an FDA-cleared, first-of-its-kind device designed to remove sagging skin on the micro-scale. ellacor® fills a much-needed gap in the market for physicians and their patients who are looking to address sagging skin and moderate to severe wrinkles in the mid to lower face in Fitzpatrick skin types I-IV.

Look at the Leaders of Cytrellis

Dr. Denise Dajles

President & CEO

Bob Hinz

VP of Operations

Sarah Brice, RN, BSN

VP of Commercial Strategy

Featured Services and Innovations

ellacor 2.0

Cutting Edge Results

Developed alongside leading physicians in the aesthetics industry, the ellacor® system’s first-of-its-kind technology removes micro-cores of dermal and epidermal tissue for the treatment of moderate to severe wrinkles in the mid and lower face without surgery. Healing time for patients is typically faster than with energy-based devices.

Company Spotlight Video

News and Stories

Cytrellis Secures FDA Clearance for Full Body Resurfacing Using Ellacor® Micro-Coring® Technology

WOBURN, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) — Cytrellis Biosystems, Inc. (“Cytrellis” or the “Company”), a medical aesthetics company bridging the gap in skin restoration, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for fractional skin resurfacing. This new indication expands ellacor’s use beyond the face, allowing medical professionals to perform ellacor procedures on any area of the body where skin laxity is a concern, such as the abdomen, knees or arms. This advancement validates the power and versatility of Cytrellis’ proprietary technology, unlocking new treatment opportunities across the growing non-surgical body aesthetics market.

Micro-Coring is The New Microneedling, But is it Better?

In recent years, we’ve prodded, poked, and probed our skin all in the name of collagen. But just when we thought we’d seen it all, enter micro-coring — a next-gen, collagen-boosting treatment that lifts and firms the skin. No lasers. No scalpels. No surgery. Think microneedling, but more advanced and less invasive. So, is this the future of skin rejuvenation and could it replace microneedling as the next celeb go-to? We investigate.

Cytrellis Strengthens Leadership Team in Support of Accelerated Commercial Growth of ellacor® Platform

WOBURN, Mass., June 02, 2025 (GLOBE NEWSWIRE) — Cytrellis Biosystems Inc., a medical technology company specializing in novel aesthetic solutions, today announced the appointment of Karyn Siemasko, Ph.D., as Vice President of Clinical and Medical Affairs; Sarah Brice, RN, BSN, as Vice President of Commercial Strategy; and Oliver Bennett as Chief Business Officer and General Counsel.

Looking to stand out from the crowd during your job search? Click below to gain access to our top tips & tools for candidates during the hiring process!

Recruiting Done Differently.

Improving lives by uniting great people with great companies.

Sign up for our Monthly Newsletter

We’re committed to sharing up-to-date industry insights, our newest career opportunities, and valuable tools to support you throughout your next job search. Let’s stay connected!